Page 24 - COVID Newsletter 11 June

Web-based portal iNoveCOP developed by ICMR for synergy
among frontline COVID institutions
ICMR has been receiving several novel claims like drug molecules, AYUSH formulations, disinfectants, devices, and tools and technologies to facilitate evaluation and validation for COVID-19. Therefore, a web-based portal called iNoveCOP has been developed by ICMR, to guide applicants on various claims related to COVID-19. Applicants may submit their claim through this portal for guidance and/or evaluation of their innovation from independent agencies. Steps to fill the claim have also been provided as a Manual in the website.
Website Link:
https://inovecop.icmr.org.in/
COVIRAP: Nucleic acid-based Point-of-Care Diagnostic Device for
COVID-19 and beyond – developed by IIT Kharagpur
IIT Kharagpur has successfully commercialized its flagship healthcare product – COVIRAP – the novel diagnostic technology for infectious diseases including COVID-19 and beyond. The product developed by lead researchers Professor Suman Chakraborty, Dr Arindam Mondal and their research group has been licensed for commercialization to the Rapid Diagnostic Group of Companies, India and Bramerton Holdings LLC, USA.
The research team has developed a more advanced version of COVIRAP using a step-wise isothermal nucleic acid testing technology for the rapid diagnostics of pathogenic infections including SARS-CoV-2 in individuals. The COVID-19 diagnostic test can be conducted
directly from human swab samples in the portable device developed by the team, without requiring any separate facility for RNA extraction. The results can be made available within 45
VOL. IV ISSUE 4
VIGYAN PRASAR 20
NATION’S S&T EFFORTS AGAINST COVID-19